VOYA Investment Management’s Y-mAbs Therapeutics YMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,742
Closed -$48.4K 2669
2025
Q2
$48.4K Buy
10,742
+531
+5% +$2.39K ﹤0.01% 2605
2025
Q1
$45.2K Sell
10,211
-1,484
-13% -$8.62K ﹤0.01% 2562
2024
Q4
$91.6K Sell
11,695
-738
-6% -$8.99K ﹤0.01% 2592
2024
Q3
$163K Sell
12,433
-168
-1% -$2.13K ﹤0.01% 2539
2024
Q2
$152K Buy
12,601
+62
+0.5% +$837 ﹤0.01% 2557
2024
Q1
$204K Sell
12,539
-3,066
-20% -$41.3K ﹤0.01% 2447
2023
Q4
$106K Sell
15,605
-22,765
-59% -$132K ﹤0.01% 2743
2023
Q3
$209K Buy
38,370
+4,024
+12% +$23.4K ﹤0.01% 2517
2023
Q2
$233K Sell
34,346
-10,893
-24% -$81.6K ﹤0.01% 2508
2023
Q1
$227K Buy
45,239
+7,594
+20% +$31K ﹤0.01% 2464
2022
Q4
$184K Buy
37,645
+9,193
+32% +$66.8K ﹤0.01% 2609
2022
Q3
$410K Hold
28,452
﹤0.01% 2152
2022
Q2
$430K Buy
28,452
+617
+2% +$7.2K ﹤0.01% 1928
2022
Q1
$331K Buy
27,835
+14,174
+104% +$146K ﹤0.01% 2132
2021
Q4
$221K Sell
13,661
-41
-0.3% -$876 ﹤0.01% 2454
2021
Q3
$391K Hold
13,702
﹤0.01% 2198
2021
Q2
$463K Sell
13,702
-4,093
-23% -$131K ﹤0.01% 2140
2021
Q1
$538K Buy
17,795
+1,572
+10% +$64.4K ﹤0.01% 1990
2020
Q4
$803K Buy
16,223
+2,779
+21% +$129K ﹤0.01% 1629
2020
Q3
$516K Buy
13,444
+3,028
+29% +$121K ﹤0.01% 1663
2020
Q2
$450K Sell
10,416
-1,368
-12% -$51.7K ﹤0.01% 1735
2020
Q1
$308K Buy
11,784
+562
+5% +$16.3K ﹤0.01% 1900
2019
Q4
$351K Buy
+11,222
New +$332K ﹤0.01% 2090

Other funds holding YMAB

VOYA Investment Management's YMAB Position: Q3 2025 in Review

VOYA Investment Management sold out of Y-mAbs Therapeutics (YMAB) in Q3 2025, closing a stake of 10,742 shares — an estimated $48.4K sold.

VOYA Investment Management first reported a position in YMAB in Q4 2019 and held it in 23 quarters. The position peaked at $803K in Q4 2020. 2 funds tracked by Wall St. Rank hold YMAB as of Q3 2025.

  • VOYA Investment Management reported no remaining Y-mAbs Therapeutics position as of Q3 2025 after selling out during the quarter.
  • VOYA Investment Management sold 10,742 Y-mAbs Therapeutics shares in Q3 2025, an estimated $48.4K.
  • VOYA Investment Management first reported a position in Y-mAbs Therapeutics in Q4 2019 and held it in 23 quarters.
  • VOYA Investment Management's Y-mAbs Therapeutics position peaked at $803K in Q4 2020.
  • 2 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q3 2025.

Based on VOYA Investment Management's 13F filing for Q3 2025, filed 9 Oct 2025.